Fortis, Spyridon
Comellas, Alejandro
Kim, Victor
Casaburi, Richard
Hokanson, John E.
Crapo, James D.
Silverman, Edwin K.
Wan, Emily S.
Article History
Received: 18 September 2019
Accepted: 17 February 2020
First Online: 20 March 2020
Competing interests
: In the past three years, Edwin K. Silverman received honoraria from Novartis for Continuing Medical Education Seminars and grant and travel support from GlaxoSmithKline. The rest of authors declare no competing interests.